Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

9 results about "Tinea corporis" patented technology

Superficial fungal infection that commonly occurs on the arms and legs

Application of betulinic acid 28-O-beta-D-glucoside in preparation of medicine for preventing and treating skin inflammation

PendingCN120204242AOrganic active ingredientsNervous disorderPityriasis roseaPimple
The invention discloses an application of betulinic acid 28-O-beta-D-glucoside (BA-6 for short) in preparation of a medicine for preventing and treating skin inflammation. The problems that an existing medicine for treating dermatitis is limited in curative effect, slow in effect taking, multiple in side effect, high in long-term use risk, large in individual difference, high in treatment cost, likely to cause immunoreaction and the like are solved. The invention discloses application of BA-6 in prevention and treatment of atopic dermatitis, contact dermatitis, eczema, rash, psoriasis, lupus erythematosus, papule squamous skin disease, pityriasis rosea, seborrheic dermatitis, pemphigus, celestial abscess, acne, tinea corporis, impetigo, SAPHO syndrome, hidradenitis suppurativa, dermatitis caused by drugs, lichen planus, pityriasis rubra pilaris, vitiligo, prurigo nodularis, dermatitis caused by drugs, and the like for the first time. The traditional Chinese medicine composition can be used for treating skin diseases, systemic sclerosis, hidradenitis suppurativa, granulomatous skin diseases, vitiligo, dermatomyositis, chronic skin itch and alopecia areata, and has the technical progress of obviously improving skin erythema, papule, edema, scale, moss and ulceration symptoms.
Owner:SUZHOU UNIV

Dry, comfortable, antibacterial and itching-relieving protection pad and preparation method thereof

The invention discloses a dry, comfortable, antibacterial and itching-relieving protection pad. The protection pad is formed by compounding a base layer and a surface layer, and the base layer is a non-woven fabric layer; and the surface layer is a medicine-carrying composite non-woven fabric layer. The protection pad surface layer is located above the base layer, the area of the protection pad surface layer is smaller than that of the base layer, and active ingredients extracted from radix sophorae flavescentis, cortex phellodendri, radix stemonae, cortex dictamni and golden larch bark and an antibacterial material polyhexamethylene biguanide are introduced into the skin-attaching non-woven fabric of the protection pad surface layer, so that the protection pad has the effects of resisting bacteria, relieving itching, clearing damp, expelling parasites and the like; the disposable disposable diaper is suitable for anorectal postoperative wound repair, prostate disease urine leakage, obesity and hidrosis and other field operation people, is particularly beneficial to tinea corporis and rotten crotch in special occasions, and has a good application prospect. The invention further discloses a preparation method of the protection pad.
Owner:THE NAVAL MEDICAL UNIV OF PLA

Topical roflumilast formulation having antifungal properties

The present invention is directed to a method of treating a fungal infection comprising administering topically, to a subject in need thereof, an anti-fungal effective amount of roflumilast. Preferably, topically administered roflumilast is used to treat fungal infections, fungal growth of and / or hypersensitivity to the fungi Malassezia spp. Patients may also be suffering from seborrheic dermatitis, dandruff, dupilumab facial redness, Tinea versicolor, Pityriasis versicolor, Tinea circinata, Tinea pedis, Tinea unguium, Tinea manus, Tinea cruris, Tinea corporis, Tinea faciei, Tinea capitis, and / or Tinea incognito. Topically administered roflumilast is a quick and effective antifungal agent and presents a viable alternative to current antifungal treatments.
Owner:ARCUTIS BIOTHERAPEUTICS INC

Laser treatment device for tinea corporis

The invention relates to the technical field of tinea corporis treatment, in particular to a tinea corporis laser treatment device which comprises a therapeutic instrument and a support, the side face of the therapeutic instrument is fixedly connected with the support, one side of the support is rotationally connected with a folding frame, one side of the therapeutic instrument is further provided with a connecting wire, and the outer side of the connecting wire is provided with a guide assembly. The other end of the connecting line is fixedly connected with a laser treatment assembly; a plurality of groups of illuminating lamps are mounted at the bottom of the bracket; limiting pins are mounted at the bracket above the illuminating lamps; the laser treatment assembly is taken out from the interior of the placement assembly, a sliding rod is pulled to be separated from a limiting groove, the distance between a supporting ring and a laser equipment pen point can be adjusted by sliding a movable sleeve, and during use, the supporting ring makes contact with a diseased area, the supporting ring can control an irradiation area at the moment, so that the treatment effect is improved. The supporting ring and the fixing rod can achieve the purpose of supporting the laser device, fatigue of the hands is relieved, and the treatment effect is guaranteed.
Owner:KEYUE (HANGZHOU) MEDICAL INFORMATION TECHNOLOGY CO LTD

Topical roflumilast formulation having antifungal properties

The present invention is directed to a method of treating a fungal infection comprising administering topically, to a subject in need thereof, an anti-fungal effective amount of roflumilast. Preferably, topically administered roflumilast is used to treat fungal infections, fungal growth of and / or hypersensitivity to the fungi Malassezia spp. Patients may also be suffering from seborrheic dermatitis, dandruff, dupilumab facial redness, tinea versicolor, pityriasis versicolor, tinea circinata, tinea pedis, tinea unguium, tinea manus, tinea cruris, tinea corporis, tinea faciei, tinea capitis, and / or tinea incognito. Topically administered roflumilast is a quick and effective antifungal agent and presents a viable alternative to current antifungal treatments.
Owner:ARCUTIS BIOTHERAPEUTICS INC

Application of luliconazole in preparation of medicine for treating mycotic tinea disease of pets

The invention belongs to the technical field of veterinary chemical preparations, and particularly relates to application of luliconazole in preparation of a medicine for treating pet fungal tinea. The invention further provides a luliconazole spray for treating the pet fungal tinea disease. The luliconazole spray is prepared from luliconazole, a solvent, a bacteriostatic agent, a transdermal enhancer, a tackifier, a pH regulator and an aromatic. The luliconazole spray prepared by the invention is simple in preparation process, has a remarkable effect on treating mycotic tinea diseases, such as claw tinea, tinea corporis, tinea cruris and the like, of pets caused by microsporum canis infection, and has a wide clinical prospect.
Owner:RINGPU TIANJIN BIOLOGICAL PHARMA

Application of betulinic acid 28-O-beta-D-glucoside in preparation of medicine for preventing and treating skin inflammation

PendingCN121891384AOrganic active ingredientsDermatological disorderPityriasis roseaPimple
The invention discloses an application of betulinic acid 28-O-beta-D-glucoside (BA-6 for short) in preparation of a medicine for preventing and treating skin inflammation. The problems that an existing medicine for treating dermatitis is limited in curative effect, slow in effect taking, multiple in side effect, high in long-term use risk, large in individual difference, high in treatment cost, likely to cause immunoreaction and the like are solved. The invention discloses application of BA-6 in prevention and treatment of atopic dermatitis, contact dermatitis, eczema, rash, psoriasis, lupus erythematosus, papule squamous skin disease, pityriasis rosea, seborrheic dermatitis, pemphigus, celestial abscess, acne, tinea corporis, impetigo, SAPHO syndrome, hidradenitis suppurativa, dermatitis caused by drugs, lichen planus, pityriasis rubra pilaris, vitiligo, prurigo nodularis, dermatitis caused by drugs, and the like for the first time. The traditional Chinese medicine composition can be used for treating skin diseases, systemic sclerosis, hidradenitis suppurativa, granulomatous skin diseases, vitiligo, dermatomyositis, chronic skin itch and alopecia areata, and has the technical progress of obviously improving skin erythema, papule, edema, scale, moss and ulceration symptoms.
Owner:SUZHOU UNIV

Topical roflumilast formulation having antifungal properties

The present invention is directed to a method of treating a fungal infection comprising administering topically, to a subject in need thereof, an anti-fungal effective amount of roflumilast. Preferably, topically administered roflumilast is used to treat fungal infections, fungal growth of and / or hypersensitivity to the fungi Malassezia spp. Patients may also be suffering from seborrheic dermatitis, dandruff, dupilumab facial redness, tinea versicolor, pityriasis versicolor, tinea circinata, tinea pedis, tinea unguium, tinea manus, tinea cruris, tinea corporis, tinea faciei, tinea capitis, and / or tinea incognito. Topically administered roflumilast is a quick and effective antifungal agent and presents a viable alternative to current antifungal treatments.
Owner:ARCUTIS BIOTHERAPEUTICS INC

Composition for beriberi, onychomycosis, tinea corporis and pruritus cutanea

The invention relates to a composition for beriberi, onychomycosis, tinea corporis and skin pruritus. The composition is prepared from the following component materials: fresh pepper alcohol extract, sweet wormwood alcohol extract, folium artemisiae argyi alcohol extract, perilla alcohol extract, negundo chastetree leaf alcohol extract, rhizoma acori graminei alcohol extract and aloe squeezed juice. The composition contains a plurality of bactericidal and anti-inflammatory substances which act together, and the fresh pepper alcohol extract has the effects of easing pain, resisting bacteria and diminishing inflammation; the artemisia apiacea alcohol extract inhibits the activity of inflammatory cells, reduces release of inflammatory mediators and can inhibit various fungi; the folium artemisiae argyi alcohol extract inhibits virus breeding and propagation; the perilla alcohol extract can inhibit pathogenic bacteria; the vitex negundo leaf alcohol extract and the rhizoma acori graminei alcohol extract can inhibit various bacteria and fungi, and the aloe squeezed juice has the effects of resisting virus infection and promoting wound recovery and can nourish skin. The composition has good prevention and treatment effects on beriberi, onychomycosis, tinea corporis and pruritus cutanea.
Owner:四川曾氏御邸科技有限公司